Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series
Eric Yuk Fai Wan, Yuan Wang, Celine Sze Ling Chui, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 7, pp. e491-e500
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Determinants of COVID-19 vaccination status and hesitancy among older adults in China
Gewei Wang, Yao Yao, Yafeng Wang, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 623-631
Open Access | Times Cited: 83
Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK
Ivan Chun Hang Lam, Carlos King Ho Wong, Ran Zhang, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102000-102000
Open Access | Times Cited: 72
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
Ivan Chun Hang Lam, Ran Zhang, Kenneth K. C. Man, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Evolution and Control of COVID-19 Epidemic in Hong Kong
Shuk‐Ching Wong, Albert Ka-Wing Au, Janice Lo, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2519-2519
Open Access | Times Cited: 47
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Journal of Infection (2022) Vol. 85, Iss. 5, pp. e140-e144
Open Access | Times Cited: 29
COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence
Altijana Hromić‐Jahjefendić, Abas Sezer, Alaa A. A. Aljabali, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1469-1469
Open Access | Times Cited: 15
Post–Vaccination Side Effects After the First Dose of Inactive CoronaVac® in Healthcare Personnel in Türkiye
Mustafa Bayraktar, Esra Çınar Tanrıverdi, Zülal Özkurt, et al.
New Trends in Medicine Sciences (2025) Vol. 6, Iss. 1, pp. 1-7
Open Access
Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications, Efficacy, and Adverse Effects of Inactivated Whole-Virus COVID-19 Vaccines Sinopharm, CoronaVac, and Covaxin: An Observational Study
Sultan Ayoub Meo, Riham A. ElToukhy, Anusha Sultan Meo, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 826-826
Open Access | Times Cited: 13
Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study
Vincent Ka Chun Yan, Franco Wing Tak Cheng, Celine Sze Ling Chui, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Population-Based Clinical Studies Using Routinely Collected Data in Hong Kong, China: A Systematic Review of Trends and Established Local Practices
Derek Wu, Ronald Hang Kin Nam, Keith Sai Kit Leung, et al.
Cardiovascular Innovations and Applications (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Enhancing vaccination uptake through community engagement: evidence from China
Hongyu Guan, Lidong Zhang, Xiangzhe Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase
Eric Yuk Fai Wan, Boyuan Wang, Sukriti Mathur, et al.
Journal of Infection (2023) Vol. 86, Iss. 6, pp. 622-625
Open Access | Times Cited: 9
Pfizer COVID19 vaccine is not associated with acute cardiovascular events excluding myocarditis– a national self-controlled case series study
Lital Keinan‐Boker, Ronen Fluss, Rita Dichtiar, et al.
Israel Journal of Health Policy Research (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case–control study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Journal of Travel Medicine (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 13
COVID-19 vaccination coverage and its cognitive determinants among older adults in Shanghai, China, during the COVID-19 epidemic
Lu Wei, Wu Zeng, Yangyang Huang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study
Simon Xiwen Qin, Franco Wing Tak Cheng, Wang Chun Kwok, et al.
Drug Safety (2023) Vol. 47, Iss. 2, pp. 135-146
Open Access | Times Cited: 7
Vaccinate with Confidence and Finish Strong
Lance E. Rodewald, Dan Wu, Zundong Yin, et al.
China CDC Weekly (2022) Vol. 4, Iss. 37, pp. 828-831
Open Access | Times Cited: 11
Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults
Oladayo A. Oyebanji, Eleftherios Mylonakis, David H. Canaday
Infectious Disease Clinics of North America (2022) Vol. 37, Iss. 1, pp. 27-45
Open Access | Times Cited: 11
Metabolomics acts as a powerful tool for comprehensively evaluating vaccines approved under emergency: a CoronaVac retrospective study
Xinyu Liu, Congshu Xiao, Pengwei Guan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Predictive value of skin testing with excipients for COVID-19 vaccines
Fabio Viggiani, Gianfranco Calogiuri, Donato Paolino, et al.
(2024), pp. 49-64
Open Access | Times Cited: 1
Association between the risk of seizure and COVID‐19 vaccinations: A self‐controlled case‐series study
Eric Yuk Fai Wan, V Ng, Richard Shek‐kwan Chang, et al.
Epilepsia (2022) Vol. 63, Iss. 12, pp. 3100-3110
Open Access | Times Cited: 7
Absence of platelet overactivation and thrombosis formation among patients with coronary atherosclerosis disease after vaccination against SARS-CoV-2
Huajie Xu, Xin Zhao, Peng Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e38336-e38336
Open Access
COVID-19 non-vaccination among older adults in China: a nationwide survey based on the China Health and Retirement Longitudinal Study (CHARLS)
Yaohui Zhao, Gewei Wang, Yao Yao, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 3
Absence of platelet overactivation and thrombosis formation among patients with coronary atherosclerosis disease after vaccination against SARS-CoV-2
Huajie Xu, Xin Zhao, Peng Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Comparative single‐cell RNA sequencing analysis of immune response to inactivated vaccine and natural SARS‐CoV‐2 infection
Shuai He, Shu‐Qiang Liu, Xiangyun Teng, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access
Page 1 - Next Page

Scroll to top